{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T15:53:38Z","timestamp":1790610818472,"version":"4.1.0"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reproductive Toxicology"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/j.reprotox.2019.07.014","type":"journal-article","created":{"date-parts":[[2019,7,23]],"date-time":"2019-07-23T11:34:48Z","timestamp":1563881688000},"page":"56-66","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["A critical evaluation of thyroid hormone measurements in OECD test guideline studies: Is there any added value?"],"prefix":"10.1016","volume":"88","author":[{"given":"Manon","family":"Beekhuijzen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen C.W.","family":"Rijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marieke","family":"Meijer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiel Alexander","family":"de Raaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia","family":"Pelgrom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"September (3)","key":"10.1016\/j.reprotox.2019.07.014_bib0005","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/bdrc.21137","article-title":"The effect of maternal exposure to endocrine disrupting chemicals on fetal and neonatal development: a review on the major concerns","volume":"108","author":"Mallozzi","year":"2016","journal-title":"Birth Defects Res. C Embryo Today"},{"key":"10.1016\/j.reprotox.2019.07.014_bib0010","series-title":"Endocrine Disrupting Chemicals in the European Union. Position Statement Endocrine Society","year":"2018"},{"key":"10.1016\/j.reprotox.2019.07.014_bib0015","unstructured":"European Commission Endocrine Disruptors Page. http:\/\/ec.europa.eu\/environment\/chemicals\/endocrine\/index_en.htm."},{"key":"10.1016\/j.reprotox.2019.07.014_bib0020","series-title":"Report of the First Meeting of the OECD Endocrine Disruptor Testing and Assessment (EDTA) Task Force","author":"OECD","year":"1998"},{"key":"10.1016\/j.reprotox.2019.07.014_bib0025","series-title":"OECD Guideline for Testing of Chemicals No. 407: Repeated Dose 28-day Oral Toxicity Study in Rodents","author":"OECD 407","year":"2008"},{"key":"10.1016\/j.reprotox.2019.07.014_bib0030","series-title":"OECD Guideline for the Testing of Chemicals. No. 416. Two Generation Reproduction Toxicity Study","author":"OECD 416","year":"2001"},{"key":"10.1016\/j.reprotox.2019.07.014_bib0035","series-title":"OECD Guideline for the Testing of Chemicals. No. 443. Extended One Generation Reproductive Toxicity Study","author":"OECD 443","year":"2018"},{"key":"10.1016\/j.reprotox.2019.07.014_bib0040","series-title":"OECD Guideline for Testing of Chemicals No. 421: Reproduction\/developmental Toxicity Screening Test","author":"OECD 421","year":"2016"},{"key":"10.1016\/j.reprotox.2019.07.014_bib0045","series-title":"OECD Guideline for Testing of Chemicals No. 422: Combined Repeated Dose Toxicity Study With the reproduction\/developmental Toxicity Screening Test","author":"OECD 422","year":"2016"},{"key":"10.1016\/j.reprotox.2019.07.014_bib0050","series-title":"OECD Guideline for the Testing of Chemicals. No. 408. Repeated Dose 90-day Oral Toxicity Study in Rodents","author":"OECD 408","year":"2018"},{"key":"10.1016\/j.reprotox.2019.07.014_bib0055","series-title":"OECD Guideline for the Testing of Chemicals. No. 414. Prenatal Developmental Toxicity Study","author":"OECD 414","year":"2018"},{"key":"10.1016\/j.reprotox.2019.07.014_bib0060","series-title":"Report of the Validation of the Updated Test Guideline 407: Repeat Dose 28-day Oral Toxicity Study in Laboratory Rats. Series on Testing and Assessment No 59, ENV\/JM\/MONO(2006)26","author":"OECD","year":"2006"},{"issue":"April (4)","key":"10.1016\/j.reprotox.2019.07.014_bib0065","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1007\/s00204-019-02436-3","article-title":"Report from the BfR expert hearing on practicability of hormonal measurements: recommendations for experimental design of toxicological studies with integrated hormonal end points","volume":"93","author":"Kucheryavenko","year":"2019","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.reprotox.2019.07.014_bib0070","series-title":"Health Implications of Perchlorate Ingestion","author":"NRC","year":"2005"},{"key":"10.1016\/j.reprotox.2019.07.014_bib0075","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/toxsci\/kfx163","article-title":"Neurodevelopment and thyroid hormone synthesis inhibition in the rat: quantitative understanding within the adverse outcome pathway framework","volume":"160","author":"Hassan","year":"2017","journal-title":"Toxicol. Sci."},{"issue":"March (3)","key":"10.1016\/j.reprotox.2019.07.014_bib0080","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1289\/ehp.9533","article-title":"Evaluation of the U.S. EPA\/OSWER preliminary remediation goal for perchlorate in groundwater: focus on exposure to nursing infants","volume":"115","author":"Ginsberg","year":"2007","journal-title":"Environ. Health Perspect."},{"key":"10.1016\/j.reprotox.2019.07.014_bib0085","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.neuro.2011.11.005","article-title":"Developmental thyroid hormone disruption: prevalence, environmental contaminants and neurodevelopmental consequences","volume":"33","author":"Gilbert","year":"2012","journal-title":"Neurotoxicology"},{"key":"10.1016\/j.reprotox.2019.07.014_bib0090","series-title":"OECD Guideline for Testing of Chemicals No. 426: Developmental Neurotoxicity Study","author":"OECD 426","year":"2007"},{"key":"10.1016\/j.reprotox.2019.07.014_bib0095","series-title":"Supportingthe Organisation of a Workshop on Thyroid Disruption \u2013 Final Report, DGEnvironment","author":"Kortenkamp","year":"2017"},{"key":"10.1016\/j.reprotox.2019.07.014_bib0100","series-title":"Guidance for Thyroid Assays in Pregnant Animals, Fetuses and Postnatal Animals, and Adult Animals","author":"US EPA (United States Environmental Protection Agency)","year":"2005"},{"key":"10.1016\/j.reprotox.2019.07.014_bib0105","series-title":"Detailed Review Paper on Thyroid Hormone Disruption Assays","author":"OECD","year":"2006"},{"issue":"September (3)","key":"10.1016\/j.reprotox.2019.07.014_bib0110","doi-asserted-by":"crossref","first-page":"496","DOI":"10.3390\/toxics2030496","article-title":"Developmental neurotoxicity of 3,3\u2032,4,4\u2032-tetrachloroazobenzene with thyroxine deficit: Sensitivity of glia and dentate granule neurons in the absence of behavioral changes","volume":"2","author":"Harry","year":"2014","journal-title":"Toxics"},{"key":"10.1016\/j.reprotox.2019.07.014_bib0115","series-title":"EU Framework Programmes for Research and Innovation","year":"2019"},{"key":"10.1016\/j.reprotox.2019.07.014_bib0120","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.yrtph.2019.04.010","article-title":"Practical considerations for developmental thyroid toxicity assessments: what\u2019s working, what\u2019s not, and how can we do better?","volume":"106","author":"Li","year":"2019","journal-title":"Regul. Toxicol. Pharmacol."},{"issue":"6","key":"10.1016\/j.reprotox.2019.07.014_bib0125","first-page":"135","article-title":"Guidance for the identification of endocrine disruptors in the context of Regulations (EU) No 528\/2012 and (EC) No 1107\/2009","volume":"16","author":"ECHA (European Chemicals Agency) and EFSA (European Food Safety Authority) with the technical support of the Joint Research Centre (JRC)","year":"2018","journal-title":"EFSA J."},{"issue":"September","key":"10.1016\/j.reprotox.2019.07.014_bib0130","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.reprotox.2018.04.017","article-title":"The urgency for optimization and harmonization of thyroid hormone analyses and their interpretation in developmental and reproductive toxicology studies","volume":"80","author":"Beekhuijzen","year":"2018","journal-title":"Reprod. Toxicol."},{"key":"10.1016\/j.reprotox.2019.07.014_bib0135","unstructured":"https:\/\/www.who.int\/ipcs\/publications\/en\/ch1.pdf."},{"key":"10.1016\/j.reprotox.2019.07.014_bib0140","unstructured":"https:\/\/echa.europa.eu."},{"key":"10.1016\/j.reprotox.2019.07.014_bib0145","unstructured":"https:\/\/ec.europa.eu\/health\/endocrine_disruptors\/process_en."},{"key":"10.1016\/j.reprotox.2019.07.014_bib0150","unstructured":"https:\/\/www.epa.gov\/endocrine-disruption."},{"key":"10.1016\/j.reprotox.2019.07.014_bib0155","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1080\/01621459.1955.10501294","article-title":"A multiple comparison procedure for comparing several treatments with a control","volume":"50","author":"Dunnett","year":"1955","journal-title":"J. Am. Stat. Assoc."},{"key":"10.1016\/j.reprotox.2019.07.014_bib0160","series-title":"Endocrine Disruptor Screening Program Test Guidelines. OPPTS 890.1450, Pubertal Development and Thyroid Function in Intact juvenile\/peripubertal Female Rats","author":"EPA (US Environmental Protection Agency)","year":"2009"},{"key":"10.1016\/j.reprotox.2019.07.014_bib0165","series-title":"Endocrine Disruptor Screening Program Test Guidelines. OPPTS 890.1500, Pubertal Development and Thyroid Function in Intact juvenile\/peripubertal Male Rats","author":"EPA (US Environmental Protection Agency)","year":"2009"},{"issue":"1","key":"10.1016\/j.reprotox.2019.07.014_bib0170","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.tox.2013.07.018","article-title":"A plea for risk assessment of endocrine disrupting chemicals","volume":"314","author":"Testai","year":"2013","journal-title":"Toxicology"},{"issue":"November","key":"10.1016\/j.reprotox.2019.07.014_bib0175","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.yrtph.2018.09.002","article-title":"Distinguishing between endocrine disruption and non-specific effects on endocrine systems","volume":"99","author":"Marty","year":"2018","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.reprotox.2019.07.014_bib0180","series-title":"Screening Methodology to Identify Potential Endocrine Disruptors According to Different Options in the Context of an Impact Assessment","author":"JRC","year":"2016"},{"key":"10.1016\/j.reprotox.2019.07.014_bib0185","unstructured":"ECETOC, CEFIC, ECPA comments on the Guidance for the identification of endocrine disruptors in the context of Regulations (EU) No 528\/2012 and (EC) No 1107\/2009 prepared by EFSA and ECHA \u2013 dated 5 July 2018 and submitted to DG Sanco."},{"key":"10.1016\/j.reprotox.2019.07.014_bib0190","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1007\/s00204-004-0644-2","article-title":"Evaluation of mechanisms inducing thyroid toxicity and the ability of the enhanced OECD Test Guideline 407 to detect these changes","volume":"79","author":"Coelho-Palermo Cunha","year":"2005","journal-title":"Arch. Toxicol."},{"key":"10.1016\/j.reprotox.2019.07.014_bib0195","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1289\/ehp.8670137","article-title":"Mechanism of nitrofen teratogenesis","volume":"70","author":"Manson","year":"1986","journal-title":"Environ. Health Perspect."},{"issue":"10","key":"10.1016\/j.reprotox.2019.07.014_bib0200","doi-asserted-by":"crossref","first-page":"845","DOI":"10.3109\/10408444.2010.494250","article-title":"Screening chemicals for thyroid-disrupting activity: a critical comparison of mammalian and amphibian models","volume":"40","author":"Pickford","year":"2010","journal-title":"Crit. Rev. Toxicol."},{"key":"10.1016\/j.reprotox.2019.07.014_bib0205","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1210\/en.2004-1018","article-title":"Bisphenol-A, an environmental contaminant that acts as a thyroid hormone receptor antagonist in vitro, increases serum thyroxin, and alters RC3\/neurogranin expression in the developing rat brain","volume":"146","author":"Zoeller","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/j.reprotox.2019.07.014_bib0210","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.tox.2007.01.020","article-title":"Negative bias from anolog methods used in the analysis of free thyroxin in rat serum containing perfluorooctanesulfonate (PFOS)","volume":"234","author":"Chang","year":"2007","journal-title":"Toxicology"},{"key":"10.1016\/j.reprotox.2019.07.014_bib0215","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1093\/toxsci\/kfn225","article-title":"The effects of triclosan on puberty and thyroid hormones in male Wistar rats","volume":"107","author":"Zorrilla","year":"2009","journal-title":"Toxicol. Sci."},{"key":"10.1016\/j.reprotox.2019.07.014_bib0220","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1177\/0192623316642527","article-title":"Characterizing \u201cadversity\u201d of pathology findings in nonclinical toxicity studies: results from the 4th ESTP international expert workshop","volume":"44","author":"Palazzi","year":"2016","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.reprotox.2019.07.014_bib0225","series-title":"New Scoping Document on In Vitro and Ex Vivo Assays for the Identification of Modulators of Thyroid Hormone Signaling. Series on Testing and Assessment No. 207","author":"OECD","year":"2014"},{"key":"10.1016\/j.reprotox.2019.07.014_bib0230","unstructured":"https:\/\/ec.europa.eu\/jrc\/en\/eurl\/ecvam\/alternative-methods-toxicity-testing\/eu-netval."}],"container-title":["Reproductive Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890623819301339?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890623819301339?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T13:49:31Z","timestamp":1760190571000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890623819301339"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,9]]},"references-count":46,"alternative-id":["S0890623819301339"],"URL":"https:\/\/doi.org\/10.1016\/j.reprotox.2019.07.014","relation":{},"ISSN":["0890-6238"],"issn-type":[{"value":"0890-6238","type":"print"}],"subject":[],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A critical evaluation of thyroid hormone measurements in OECD test guideline studies: Is there any added value?","name":"articletitle","label":"Article Title"},{"value":"Reproductive Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reprotox.2019.07.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}